A randomized, multicenter, open-label, parallel, phase 4 study to compare atorvastatin and ezetimibe combination therapy with atorvastatin monotherapy in patients with hypercholesterolemia and type 2 diabetes mellitus.

Authors
Category Primary study
Registry of TrialsKorean Clinical Trials Database
Year 2025
This article has no abstract
Epistemonikos ID: 08b78e07fc9f1bacd5c89e5159c7377e62e85ea5
First added on: Apr 22, 2026